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Abstract 
Introduction: When treating periprosthetic joint infection with a two-stage procedure, 
antibiotic-impregnated spacers can be used in the interval between prosthetic removal and 
reimplantation. In our experience, cultures of sonicated spacers are most often negative. The objective of 
the study was to assess whether that sonication causes an elution of antibiotics, leading to elevated 
antibiotic concentrations in the sonication fluid inhibiting bacterial growth and thus causing false-negative 
cultures.  
Methods: A prospective monocentric study was performed from September 2014 to March 2016. 
Inclusion criteria were a two-stage procedure for prosthetic infection and agreement of the patient to 
participate in the study. Spacers were made of gentamicin-containing cement to which tobramycin and 
vancomycin were added. Antibiotic concentrations in the sonication fluid were determined by 
mass-spectometry (LC-MS). 
Results: 30 patients were identified (15 hip and 14 knee and 1 ankle arthroplasties). No cases of culture 
positive sonicated spacer fluid were observed in our serie. In the sonication fluid median concentrations 
of 13.2µg/ml, 392 µg/ml and 16.6 µg/ml were detected for vancomycin, tobramycin and gentamicin, 
respectively.  According to the European Committee on antimicrobial susceptibility testing (EUCAST), 
these concentrations released from cement spacer during sonication are higher than the minimal 
inhibitory concentrations (MICs) for most bacteria relevant in prosthetic joint infections. 
Conclusion: Spacer sonication cultures remained sterile in all of our cases. Elevated concentrations of 
antibiotics released during sonication could explain partly negative-cultured sonicated spacers. Indeed, 
the absence of antibiotic free interval during the two-stages can also contribute to false-negative spacers 
sonicated cultures. 
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Introduction 
Periprosthetic joint infection is a common 
complication following joint arthroplasty, estimated 
at 1 and 2% for total hip arthroplasty and total knee 
arthroplasty, respectively. As the incidence of 
prosthetic joint replacements increases, the infection 
problem is going to remain an important issue in the 
future.  
One of the possible options for the treatment of 
periprosthetic joint infections is a two-stage exchange 
procedure. During the interval between removal of 
the prosthesis and reimplantation, antibiotic- 








the advantages of local antibiotic release, dead space 
management and prevention of soft tissue retraction. 
However, the spacer can also act as a foreign body 
and thus be colonized by biofilm forming 
microorganisms. In the literature, most studies report 
cases of spacer infection at the second-stage 
procedure [1-4]. 
Sonication is a method to take off the bacterial 
biofilm containing adherent microorganisms on a 
prosthetic implant by ultrasound. By this process, the 
bacteria return to a planktonic state, can be incubated 
and analyzed. It increases significantly the sensitivity 
of bacterial cultures from 61% for standard cultures to 
79% after sonication [5]. This is thus a useful method 
for diagnosis of periprosthetic infection. However, its 
use for diagnosis of persistent infection at the spacer 
stage is unclear so far.   
According to Nelson et al [1], 50% of their 
removed and sonicated spacers were infected at the 
time of the second stage procedure. In the group with 
positive sonication results, 50% of patients had a 
re-infection at 2 years follow-up. In our experience, 
cultures of sonicated spacers were always negative. 
However, in their series, the interval during the 
two-stages was longer and antibiotics were 
suspended 6 weeks before reimplantation. Those two 
reasons could increase the probability to identify 
persistent infection. 
The objective of the study was to assess whether 
that spacer sonication causes an elution of antibiotics, 
leading to elevated antibiotic concentrations in the 
sonication fluid inhibiting bacterial growth and 
causing false-negative cultures. 
Method 
A prospective monocentric study was performed 
from September 2014 to March 2016 at the Lausanne 
University Hospital (CHUV). Inclusion criteria were 
patients who were operated for a periprosthetic joint 
infection treated with two-stage exchange and who 
gave their informed consent to the study. The study 
was approved by the local ethical committee.   
The diagnosis of infection was confirmed either 
by multiple positive periprosthetic cultures and/or, 
sonication of the prosthesis at the first stage of the 
procedure. The threshold of ≥50 CFU was defined as 
positive cultures, being a sign of infection [5]. 
Moreover, patients with fistula were considered 
infected even if all cultures samples were negative. 
30 consecutive patients were included: 15 total 
hip arthroplasty (THA), 14 total knee arthroplasty 
(TKA), 1 total ankle arthroplasty (TAA). 8 patients 
were female and 22 were male. 8 patients were 
diabetic (26.6%). Mean age was 66 years old (range 
28-85).  The bacteria identified were Staphylococcus 
epidermidis (8), S. aureus (7), S. capitis (3), Streptococcus 
dysgalactiae (4), S. milleri (2), S. pneumoniae (1), S. 
salivarius (1), Enterococcus faecalis (1), Cutibacterium 
acnes (1), Clostridium celecrescens (1) and Campylobacter 
fetus (1).  
At the first stage of the procedure, the prosthesis 
was removed and was sent for sonication to the 
laboratory of microbiology [5-6], Wide debridement 
was performed collecting at least 2-3 periprosthetic 
tissues samples  which were sent for culture. Then a 
handmade spacer was formed. For the production of 
the spacer 40g of the shelf cement containing 0,5gr of 
gentamycin (Palacos R+G, Hereaus Medical, Berlin, 
GER) were handmixed with supplemental 1.2g 
tobramycin and 2g vancomycin. Empiric intravenous 
antibiotics were administrated postoperatively 
followed by specific intravenous antibiotics, once the 
susceptibility tests were available. Rifampin was not 
introduced before the second stage was completed, in 
order to avoid development of rifampin-resistant 
bacteria. Indeed, Achermann et al proved that PJI 
with high initial bacterial load, inappropriate initial 
debridement and length of intravenous antibiotics 
shorter than 2 weeks were risk factors to develop 
resistance to rifampin. Moreover, in presence of 
wound discharge or sinus tract, the use of rifampin 
could select rifampin-resistant skin micro-organisms 
and could cause surinfection. They also attested that 
even if rifampin is postponed for several days, it does 
not alter survival rate of the prosthetic implant. For 
those reasons, we chose to introduce rifampin only 
after the second stage, when wound was calm [7]. 
A short interval from 2 to 4 weeks was chosen for 
each case; the best time of reimplantation being 
decided depending on local status (acceptable quality 
of bone or soft tissue at the time of implant removal), 
pathogen involved (absence of difficult-to-treat 
microorganisms such as rifampicin-resistant 
staphylococci, ciprofloxacin-resistant gram-negative 
bacteria, fungi) and decreasing of C-reactive protein 
(CRP) and white cell count, without any strict cut-off 
value. No antibiotic free period was performed 
between the 2 stages. 
At the second stage, the spacer was removed, a 
wide debridement was performed and the new 
prosthesis was implanted. At this stage, cultures of 2-3 
samples were done and the spacer was sonicated. For 
the purpose of the study, concentration of each 
antibiotic in the sonication fluid was measured.  
Our protocol of sonication consists in two 
minutes at 40kHz using sonication device Bactosonic 
(Bandelin GmbH, Berlin, Germany). It was based on 
the protocol published by Trampuz et al, and adapted 
according to the Microlabs standard operating 
procedures [5]. A minimum of phosphate buffered 




saline (PBS) fluid was poured in the sterile container 
containing the spacer. The quantity of fluid was 
depending on the size of the spacer. Unfortunately, 
the quantity could not be standardized for every case 
and was not measured systematically. Therefore, the 
concentration of antibiotics is only indicative for the 
purpose of the study. It does not imply that the 
antibiotic concentrations are efficient enough to treat 
locally the infection. Indeed, these are ex vivo 
antibiotic concentrations and do not represent the 
local concentration of antibiotics around the spacer in 
the patient.  
After sonication, a sample of sonication fluid 
was collected under laminar flow for measurement of 
antibiotic concentration. Antibiotic concentrations in 
the sonication fluid were determined by liquid 
chromatography associated with mass-spectometry 
(LC-MS). 
The analysis was performed during the first 3-4 
days after sonication and samples were kept at -80 
Celsius degrees between the different stages of the 
procedure.   
Results 
At reimplantation, cultures of tissue samples and 
spacer sonication fluid were all negative.  
At a mean follow-up of 12.8 months (range from 
1 to 24 months), we had two persistent infections: one 
patient infected with S. epidermidis and one patient 
infected with methicilin-resistant S. aureus (MRSA). 
Four patients had a re-infection (13.3%): one 
hematogenous THA infection by S. aureus caused by 
diabetic foot ulcer 9 months later, one hematogenous 
THA infection by S. aureus 5 months later and two 
cases of persistent serous discharge of wound 1 month 
after reimplantation (1 THA infection by E. faecalis and 
1 TKA infection by E. cloacae). As the bacteria 
identified were different from the first stage 
procedure, they were treated by debridement, 
changing of the mobile part and implant retention. 
Re-infection appeared between 1 and 8 months after 
reimplantation (mean: 3.5 months). 
In the sonication fluid, median concentrations of 
13.2µg/ml (min. 1.4 µg/ml, max 49.2 µg/ml), 39.2 
µg/ml (min. 0 µg/ml, max 1068,8 µg/ml), and 16.6 
µg/ml (min 0 µg/ml, max 169.7 µg/ml) were detected 
for vancomycin, tobramycin and gentamicin, 
respectively (Table 1). The detailed antibiotic 
concentrations are listed in Table 2. According to the 
European Committee on antimicrobial susceptibility 
testing (EUCAST), these antibiotic concentrations 
released from cement spacer during sonication are 
higher than the minimal inhibitory concentrations 
(MICs) for most bacteria relevant in PJI (Table 3). Only 
one case (Case 7) showed antibiotic concentration for 
S. aureus lower than MIC. Moreover, despite 
standardized protocol and operative report, 
tobramycin and vancomycin were not mixed to the 
Palacos R+G cement.  
 
Table 1. Mean antibiotic concentrations in spacer sonicated fluid 






Median 16.6 392 13.2 
Min; Max 2.2; 169.7 4.7; 1068 1.4; 49.2 
 
Discussion 
In our serie, the survival rate free-of infection 
was 80 % at a mean follow-up of 12.8 months. Those 
results are similar to other studies where survival 
rates were between 67% and 94% [1],[9],[10],[8],[11]. 
Four on six infections in our serie were newly 
acquired infections with different germs compared to 
the initial infection in 3 cases. Two cases were 
persistent infections. We can conclude that 28 on 30 
cases were true-negative spacer sonication cultures.  
From the literature, we already know that 
bacteria can adhere on cement spacer despite a high  
load of  antibiotics [12]. In vitro and in vivo studies 
have shown that antibiotics are released from cement 
spacers in high concentrations during the first few 
days after implantation [13-14]. After a peak of 
antibiotic levels during the few days of spacer 
implantation, a lower residual antibiotic 
concentration persists during the following weeks 
[15-16]. 
In our study and after explantation of the spacer, 
the concentrations of antibiotics in the spacer 
sonication fluid were sufficiently high for microbial 
growth inhibition of most bacteria responsible for 
prosthetic joint infection, even if important variability 
between patients was observed. However, the volume 
of fluid used in the sonication process was not 
standardized; those results do not represent the in 
vivo concentrations. Hendricks et al also 
demonstrated that sonication tends to increase 
antibiotic release in vitro [17]. The same results were 
found by Kummer et al. In vitro polymethyl 
methacrylate (PMMA) scaffolds containing antibiotics 
were stored in 37°C for up to 6 weeks. Sonication 
increased antibiotics elution, especially during the 
first 2 weeks. The release was more stable for 
vancomycin, in comparison with gentamycin that 
decreased over time. However, all concentrations 
were above MICs of microorganisms responsible for 
most frequent PJI infection [18]. Ensing et al added 
that increased antibiotic release from cement blocks 
by ultrasounds is active on bacteria in planktonic state 
as bacteria in biofilms. However, the efficiency of 




antibiotics differs depending on the germs. Indeed, S. 
aureus and Coagulase-negative staphylococcus are more 
susceptible than Pseudomonas [19]. However, Clauss et 
al disagree with the results cited above. In their study 
in vitro, in which PMMA samples were exposed to 
bacteria for 1-2 days, bacterial growth was not altered 
by release of antibiotics. They found >500CFU/ml in 
sonication fluid when S. aureus and E. faecalis were 
tested. However, C. acnes was influenced by antibiotic 
release. That phenomenon increased by a longer 
interval between sonication and time of analysis [20]. 
This shows that the reaction is different depending on 
the bacteria involved.  
Table 2. Detailed antibiotic concentrations  
Patients Implants Primary infection Antibiotics concentrations Re-infection 
   Gentamicin  mg/l Tobramycin mg/l Vancomycin mg/l  
1 THR Streptococcus dysgalactiae 8.12 64.98 19.216 None 
2 TKR S. epidermidis 39.49 185.064 89.733 Persistent infection with cutaneous fistula 
3 THR methicilin-resistant S. epidermidis 5.062 7.841 5.652 None 
4 THR Cutibacterium acnes 4.916 4.675 3.491 None 
5 THR methicilin-resistant S. epidermidis 9.893 16.879 7.148 None 
6 THR S. aureus 25.53 37.708 17.398 Re-infection by S. aureus 
7 TKR S. aureus 1.439 0 0 None 
8 THR S. epidermidis 16.134 76.711 81.183 None 
9 THR methicilin-resistant S. epidermidis 6.665 7.166 2.489 Re-infection by Enterococcus faecalis 
10 TAR Staphylococcus capitis 13.152 12.404 5.554 None 
11 TKR Streptococcus pneumoniae 8.2 13.9 3.3 None 
12 THR Enterococcus faecalis 33 66.6 17.7 None 
13 THR S. aureus 49.2 153.3 77.7 None 
14 THR S. epidermidis 17 15.6 2.5 None 
15 TKR Streptococcus dysgalactiae 22.92 99.721 169.686 Re-infection by Staph aureus 
16 TKR methicillin-resistant S. aureus 10.716 39.208 16.624 Re-infection by Enterobacter cloacae 
17 THR Streptococcus milleri 4.65 5.00 2.56 None 
18 TKR Streptococcus salivarus 10.36 5.89 2.30 None 
19 TKR Streptococcus dysgalactiae 43.42 884.94 285.92 None 
20 THR Campylobacter fetus 23.86 25.43 200.94 None 
21 TKR Streptococcus milleri 23.63 425.23 2.76 None 
22 TKR methicillin-resistant S. aureus 25.85 1068.61 371.35 None 
23 TKR methicillin-resistant S. aureus 24.36 751.26 8.99 Persistent infection with cutaneous fistula 
24 TKR Streptococcus dysgalactiae 9.79 6.20 213.85 None 
25 THR S. epidermidis 42.38 84.92 24.84 None 
26 THR Staphylococcus capitis 1.50 17.62 15.62 None 
27 TKR Clostridium celerecrescens 8.08 6.18 2.19 None 
28 TKR methicilin-resistant S. epidermidis 24.03 460.7 107.29 None 
29 THR S. aureus 9.12 16.08 6.53 None 
30 TKR Staphylococcus capitis 64.28 1068.8 225.93 None 











Staphylococcus aureus 1 1 2 
Coagulase-Negative 
Staphylococcus  
1 1 4 
Streptococcus spp - - 2 
Enterobacteriae 2-4 2 - 
Pseudomonas spp 4 4 - 
Enterococcus spp - - 4 
Corynebacterium spp 1 - 2 
Acinebacter spp 4 4 - 
Clostridium difficile - - 2 
Gram positive anaerobes - - 2 
Cutibacterium acnes - - - 
Campylobacter spp - - - 
Spp= species; - = not available; Values from “The European Committee on 
Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs 
and zone diameters. Version 7.1. 2017. http://www.eucast.org. 
Concerning in vivo studies, there is no consensus 
on the quantity and type of antibiotics needed in 
spacers. Corona et al. have tested spacers containing 
different loads of antibiotics, either gentamicin alone, 
or gentamicin and vancomycin [21]. However, there 
was no statistically significant difference between 
different groups in terms of re-infection and 
complication rate. Those results are similar to the 
study of Nettrour which showed 88% of survival free 
of infection, with no difference between groups 
(tobramycin, vancomycin or both of them; with dose 
of antibiotics contained in the cement either below or 
above 4g) [11]. Nevertheless, some authors published 
that association of antibiotics would be more efficient 
than one antibiotic alone due to synergic effect 
[13],[15]. The quantity of antibiotics is then at the 
discretion of the surgeon.  




In our study, the combination of 3 antibiotics 
was chosen; vancomycin to cover Gram positive 
infection, tobramycin to cover Gram negative and 
gentamicin already present in the cement; to be active 
against all bacteria mostly responsible for prosthetic 
joint infection, even the more virulent ones. Based on 
our experience a short interval exchange, once the 
micro-organism is identified at the first stage 
procedure, is an acceptable option for eradication of 
infection. IV- antibiotics were continued during the 
whole interval between the two stages. From our 
point of view, this limits the risk of colonization of the 
cement spacer. 
However, even with standardized protocols, 
local antibiotics concentrations have shown some 
discrepancy between individuals. Indeed, elution 
depends on surface area, that is different for each joint 
and each patient due to the centromedullary width 
and size of the bones; characteristics and quantity of 
antibiotics, and characteristics of bone cement 
(porosity and roughness) [3],[22]. The type of spacer 
used does not seem to interfere significantly with 
antibiotic release. In their review, Pivec et al. showed 
no difference in re-infection rate in articulating versus 
static spacers in TKA [23]. Moreover, handmade 
versus prefabricated spacers had similar re-infection 
rates. The only significant difference was a tendency 
of increased dislocation, and fracture rate for spacers 
made intraoperatively by the surgeon [24].  
In conclusion, in our study of explanted spacers, 
antibiotic concentrations released from cement spacer 
during sonication are high enough to cause 
culture-negative spacer sonicated fluid. Therefore, 
sonication of cement spacers does not seem relevant 
for diagnostic purposes. Indeed, a negative spacer 
sonication does not confirm that periprosthetic 
infection is completely cured. However, the absence 
of an antibiotic free interval in our serie between the 
two-stages can also contribute to false-negative 
cultures.   
Our study has some limitations. The number of 
patients is relatively small, although relatively high 
compared to most studies on spacers sonication. The 
difference of spacer size between patients and the 
absence of standardization of the quantity of liquid in 
sonication are also issues to measure precisely 
antibiotic concentrations. This explains the variation 
of antibiotic concentration between patients in our 
series and this is the reason why our results should 
not be compared with in vivo studies. Indeed, the 
antibiotic concentrations in our study are not 
representative of the local antibiotic concentration 
around the spacer in the patient. The length of 
follow-up of our study can also be considered too 
short to highlight low-grade bacteria such as 
Cutibacterium acnes and Enterococci. However, the aim 
of this study was to measure the elution of antibiotics 
out of the explanted spacer through sonication.  
Conclusions 
Spacer sonication cultures remained sterile in all 
of our cases. Elevated concentrations of antibiotics 
released during sonication could explain at least 
partly negative-cultured sonicated spacers. Therefore, 
sonication of cement spacers does not seem relevant 
for diagnostic purposes. Indeed, a negative spacer 
sonication does not confirm the absence of 
periprosthetic infection and does not help to predict 
which patients will suffer from a persistent infection. 
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